MedTrace Logo

OCTA in Cardiovascular Disease and Healthy Controls

NCT07359664 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2026-01-22

No results posted yet for this study

Summary

This prospective clinical study will involve the non-invasive assessment of retinal vessels using OCTA (Cirrus OCT 6000 AngioPlex) and scanning laser Doppler flowmetry (SLDF) in patients with cardiovascular disease and healthy individuals. The study will be conducted at the Clinical Research Centre (CRC), Department of Nephrology and Hypertension at the University of Erlangen-Nuremberg.

Conditions

  • Patients With Cardiovascular Disease
  • Healthy Participants

Interventions

DIAGNOSTIC_TEST

Retinal vascular assessment using OCTA and SLDF

Assessment of retinal capillary density using OCTA and SLDF

Sponsors & Collaborators

  • German Diabetes Association

    collaborator OTHER

  • University of Erlangen-Nürnberg Medical School

    lead OTHER

Principal Investigators

  • Agnes Bosch, MD · Clinical Research Center, Department of Nephrology and Hypertension, Universityhospital Erlangen

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-12-01
Primary Completion
2026-12-31
Completion
2027-03-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07359664 on ClinicalTrials.gov